NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $9,347,000 | -19.5% | 156,517 | -67.6% | 0.74% | -24.1% |
Q3 2017 | $11,611,000 | +29.3% | 483,800 | +5.4% | 0.97% | +17.0% |
Q2 2017 | $8,977,000 | -32.0% | 459,201 | -18.4% | 0.83% | -37.6% |
Q1 2017 | $13,201,000 | -40.8% | 562,473 | -69.0% | 1.32% | +73.0% |
Q4 2016 | $22,286,000 | -34.9% | 1,816,305 | -8.9% | 0.77% | -31.7% |
Q3 2016 | $34,242,000 | +21.5% | 1,993,125 | +0.6% | 1.12% | +9.2% |
Q2 2016 | $28,180,000 | -0.1% | 1,980,335 | -3.5% | 1.03% | +0.1% |
Q1 2016 | $28,213,000 | -19.6% | 2,051,835 | -1.5% | 1.03% | -15.0% |
Q4 2015 | $35,084,000 | +38.0% | 2,082,155 | -10.2% | 1.21% | +53.4% |
Q3 2015 | $25,424,000 | -8.2% | 2,319,675 | +4.8% | 0.79% | +0.4% |
Q2 2015 | $27,682,000 | +13.5% | 2,212,775 | -0.2% | 0.78% | +12.3% |
Q1 2015 | $24,386,000 | -55.2% | 2,216,945 | -36.8% | 0.70% | -56.0% |
Q4 2014 | $54,405,000 | +30.9% | 3,509,990 | +1.9% | 1.59% | +23.8% |
Q3 2014 | $41,557,000 | -11.8% | 3,442,980 | -6.3% | 1.28% | -6.7% |
Q2 2014 | $47,105,000 | +5.2% | 3,674,326 | -0.5% | 1.38% | +14.0% |
Q1 2014 | $44,771,000 | +22.2% | 3,693,956 | +14.4% | 1.21% | +28.0% |
Q4 2013 | $36,637,000 | +29.2% | 3,227,906 | +18.9% | 0.94% | +25.1% |
Q3 2013 | $28,356,000 | -14.9% | 2,714,830 | -5.9% | 0.75% | -21.5% |
Q2 2013 | $33,336,000 | – | 2,886,200 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $82,950,000 | 2.19% |
MAVERICK CAPITAL LTD | 5,678,221 | $94,202,000 | 1.75% |
Rhenman & Partners Asset Management AB | 1,000,000 | $16,590,000 | 1.48% |
Goodman Financial Corp | 119,198 | $1,977,000 | 0.92% |
Bellevue Group AG | 3,632,358 | $60,261,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 477,004 | $7,914,000 | 0.53% |
Parametrica Management Ltd | 13,658 | $226,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 592,930 | $9,837,000 | 0.40% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,110,000 | 0.36% |
Burleson & Company, LLC | 92,836 | $1,617,000 | 0.31% |